APA (7th ed.) Citation

VL, d. R., K, M., LG, D., T, B., & F, P. (2026). Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction. Neuromolecular medicine, 28(1), . https://doi.org/10.1007/s12017-026-08912-1

Chicago Style (17th ed.) Citation

VL, de Rezende, Mathias K, Danielski LG, Barichello T, and Petronilho F. "Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction." Neuromolecular Medicine 28, no. 1 (2026). https://doi.org/10.1007/s12017-026-08912-1.

MLA (9th ed.) Citation

VL, de Rezende, et al. "Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as a Biomarker of Neurodysfunction." Neuromolecular Medicine, vol. 28, no. 1, 2026, https://doi.org/10.1007/s12017-026-08912-1.